scholarly journals Convalescent plasma for administration of passive antibodies against viral agents

Haematologica ◽  
2020 ◽  
Vol 105 (12) ◽  
pp. 2710-2715
Author(s):  
Giovanni Di Minno ◽  
Pier Mannuccio Mannucci ◽  
James W. Ironside ◽  
Carlo Federico Perno ◽  
Lutz Gürtler ◽  
...  
Keyword(s):  
Passive Antibodies

Inability of passive antibodies to reverse the effects of dioxin toxicity

Chemosphere ◽  
1978 ◽  
Vol 7 (1) ◽  
pp. 29-34 ◽  
Author(s):  
Michael I. Luster ◽  
Phillip W. Albro ◽  
Robert E. Faith ◽  
Lea D. Lawson
Keyword(s):  
Passive Antibodies ◽  
Dioxin Toxicity

scholarly journals Levels of passive antibodies against Aujeszky's disease virus in piglets derived from infected sows.

1986 ◽  
Vol 48 (3) ◽  
pp. 633-635 ◽  
Author(s):  
Hideo KOMANIWA ◽  
Tomomitsu MAKABE ◽  
Masahiko FUKUDA ◽  
Takashi OGAWA ◽  
Hideo HATAKEYAMA
Keyword(s):  
Disease Virus ◽  
Aujeszky's Disease ◽  
Aujeszky’S Disease ◽  
Aujeszky’S Disease Virus ◽  
Passive Antibodies

scholarly journals Acquisition of Maternal Antibodies both from the Placenta and by Lactation Protects Mouse Offspring from Yersinia pestis Challenge

2012 ◽  
Vol 19 (11) ◽  
pp. 1746-1750 ◽  
Author(s):  
Zhizhen Qi ◽  
Haihong Zhao ◽  
Qingwen Zhang ◽  
Yujing Bi ◽  
Lingling Ren ◽  
...  
Keyword(s):  
Yersinia Pestis ◽  
Subunit Vaccine ◽  
Protective Efficacy ◽  
Passive Immunization ◽  
Maternal Antibodies ◽  
Newborn Mice ◽  
Content Type ◽  
Specific Antibodies ◽  
Transmission Modes ◽  
Passive Antibodies

ABSTRACTArtificially passive immunization has been demonstrated to be effective againstYersinia pestisinfection in animals. However, maternal antibodies' protective efficacy against plague has not yet been demonstrated. Here, we evaluated the kinetics, protective efficacy, and transmission modes of maternal antibodies, using mice immunized with plague subunit vaccine SV1 (20 μg of F1 and 10 μg of rV270). The results showed that the rV270- and F1-specific antibodies could be detected in the sera of newborn mice (NM) until 10 and 14 weeks of age, respectively. There was no antibody titer difference between the parturient mice immunized with SV1 (PM-S) and the caesarean-section newborns (CSN) from the PM-S or between the lactating mice immunized by SV1 (LM-S) and the cross-fostered mice (CFM) during 3 weeks of lactation. The NM had a 72% protection against 4,800 CFUY. pestisstrain 141 challenge at 6 weeks of age, whereas at 14 weeks of age, NM all succumbed to 5,700 CFU ofY. pestischallenge. After 7 weeks of age, CFM had an 84% protection against 5,000 CFU ofY. pestischallenge. These results indicated that maternal antibodies induced by the plague subunit vaccine in mother mice can be transferred to NM by both placenta and lactation. Passive antibodies from the immunized mothers could persist for 3 months and provide early protection for NM. The degree of early protection is dependent on levels of the passively acquired antibody. The results indicate that passive immunization should be an effective countermeasure against plague during its epidemics.

Modulation of the immune response by passive antibodies

1976 ◽  
Vol 27 (2) ◽  
pp. 328-331 ◽  
Author(s):  
P.J. Neveu ◽  
V.V. Micusan ◽  
A.G. Borduas
Keyword(s):  
Immune Response ◽  
Passive Antibodies

scholarly journals Immune Responses of 6, 9, and 12 Month Old Infants Immunized with Measles or Mumps Vaccine and the Effects of Passive Antibodies on These Responses

1999 ◽  
Vol 45 (4, Part 2 of 2) ◽  
pp. 161A-161A ◽  
Author(s):  
H A Gans ◽  
L Lew-Yasukawa ◽  
J Beeler ◽  
R DeHovitz ◽  
Y Maldonado ◽  
...  
Keyword(s):  
Immune Responses ◽  
Mumps Vaccine ◽  
Passive Antibodies

scholarly journals Neutralization of measles virus wild-type isolates after immunization with a synthetic peptide vaccine which is not recognized by neutralizing passive antibodies

2000 ◽  
Vol 81 (3) ◽  
pp. 729-735 ◽  
Author(s):  
Karim C. El Kasmi ◽  
Dietmar M. Theisen ◽  
Heike Hartter ◽  
Sophie Fillon ◽  
Claude P. Muller ◽  
...  
Keyword(s):  
Synthetic Peptide ◽  
Measles Virus ◽  
Peptide Vaccine ◽  
Wild Type ◽  
Synthetic Peptide Vaccine ◽  
Passive Antibodies
Sign in / Sign up

Export Citation Format

Share Document